InMode Ltd. (INMD) vs SpyGlass Pharma, Inc. Common Stock (SGP)

A side-by-side comparison of InMode Ltd. and SpyGlass Pharma, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — INMD vs SGP

growth of $100 · dividends reinvested · last 1y
INMD -4.7% (-4.7%/yr)SGP -3.1% (-3.1%/yr)SGP compounded faster over this window
708090100110Start $100$95$97
INMD SGP

INMD vs SGP: by the numbers

  • •SGP is the larger company ($828M vs $804M market cap).
  • •INMD is profitable (20.69% net margin) while SGP runs a net loss (0.00%).

Metrics side by side

Valuation

MetricINMDSGP
P/E ratio11.37N/A
Forward P/E10.79N/A
PEG ratio1.14N/A
P/S ratio2.15N/A
P/B ratio1.283.57
EV / EBITDA5.90N/A
FCF yield10.88%N/A

Profitability

MetricINMDSGP
Gross margin76.52%0.00%
Operating margin18.47%0.00%
Net margin20.69%0.00%
ROE12.32%-24.12%
ROIC9.20%-26.54%

Growth (annualized)

MetricINMDSGP
Revenue CAGR (5Y)5.42%N/A
EPS CAGR (5Y)6.87%N/A
FCF CAGR (5Y)1.36%N/A
Total return CAGR (5Y)-27.48%N/A

Frequently asked

Is INMD or SGP more profitable?
INMD runs the higher net margin — INMD at 20.69% versus SGP at 0.00%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.